Your browser doesn't support javascript.
loading
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.
Béreau, Matthieu; Castrioto, Anna; Servant, Mathieu; Lhommée, Eugénie; Desmarets, Maxime; Bichon, Amélie; Pélissier, Pierre; Schmitt, Emmanuelle; Klinger, Hélène; Longato, Nadine; Phillipps, Clélie; Wirth, Thomas; Fraix, Valérie; Benatru, Isabelle; Durif, Franck; Azulay, Jean-Philippe; Moro, Elena; Broussolle, Emmanuel; Thobois, Stéphane; Tranchant, Christine; Krack, Paul; Anheim, Mathieu.
Afiliación
  • Béreau M; Neurology Department, University Hospital of Besançon, CHRU de Besançon, 3 Bd Alexandre Fleming, 25030, Besançon Cedex, France. mbereau@chu-besancon.fr.
  • Castrioto A; Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Université Bourgogne Franche-Comté, Besançon, France. mbereau@chu-besancon.fr.
  • Servant M; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Lhommée E; Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Université Bourgogne Franche-Comté, Besançon, France.
  • Desmarets M; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Bichon A; Unité de Méthodologie, CIC INSERM 1431, CHU de Besançon, Besançon, France.
  • Pélissier P; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Schmitt E; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Klinger H; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Longato N; Movement Disorders Unit, Neurology Department, Hospices Civils de Lyon, Lyon, France.
  • Phillipps C; Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Wirth T; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron, France.
  • Fraix V; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Benatru I; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Durif F; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Azulay JP; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104, Université de Strasbourg, Illkirch, France.
  • Moro E; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
  • Broussolle E; Inserm, U1216, Grenoble Institut Neurosciences, CHU Grenoble Alpes, University Grenoble Alpes, 38000, Grenoble, France.
  • Thobois S; Neurology Department, University Hospital of Poitiers, Poitiers, France.
  • Tranchant C; INSERM, CHU de Poitiers, Centre d'Investigation Clinique CIC1402, University of Poitiers, Poitiers, France.
  • Krack P; EA7280 NPsy-Sydo, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Anheim M; Neurology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Sci Rep ; 13(1): 21234, 2023 12 01.
Article en En | MEDLINE | ID: mdl-38040775
ABSTRACT
Few studies have considered the influence of motor sign asymmetry on motivated behaviors in de novo drug-naïve Parkinson's disease (PD). We tested whether motor sign asymmetry could be associated with different motivated behavior patterns in de novo drug-naïve PD. We performed a cross-sectional study in 128 de novo drug-naïve PD patients and used the Ardouin Scale of Behavior in Parkinson's disease (ASBPD) to assess a set of motivated behaviors. We assessed motor asymmetry based on (i) side of motor onset and (ii) MDS-UPDRS motor score, then we compared right hemibody Parkinson's disease to left hemibody Parkinson's disease. According to the MDS-UPDRS motor score, patients with de novo right hemibody PD had significantly lower frequency of approach behaviors (p = 0.031), including nocturnal hyperactivity (p = 0.040), eating behavior (p = 0.040), creativity (p = 0.040), and excess of motivation (p = 0.017) than patients with de novo left hemibody PD. Patients with de novo left hemibody PD did not significantly differ from those with de novo right hemibody PD regarding avoidance behaviors including apathy, anxiety and depression. Our findings suggest that motor sign asymmetry may be associated with an imbalance between motivated behaviors in de novo drug-naïve Parkinson's disease.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Apatía Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Apatía Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Francia